Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
Corey Smith(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Katherine Matthews, Sandro Porceddu(Peter MacCallum Cancer Centre), Benedict Panizza(The University of Queensland), Randal Tiu(University of Hong Kong), John M. Nicholls(University of Hong Kong), Emma Gostick(John Radcliffe Hospital), Andrea Schuessler, Glen M. Boyle(Queensland University of Technology), Michelle A. Neller(QIMR Berghofer Medical Research Institute), David A. Price(University Hospital of Wales), Victor Lee(University of Ottawa), Vivian Li(Queen Mary Hospital), Daniel T. T. Chua(Chinese University of Hong Kong), Dora L.�W. Kwong(University of Hong Kong), Janice Tsang(The University of Queensland), Jacqueline M. Burrows(QIMR Berghofer Medical Research Institute), Leone Beagley, David C. Smith(University of Michigan), Sweera Rehan(QIMR Berghofer Medical Research Institute)
Cited by 72
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k